PolyPeptide Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 76.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
56.3%	Draupnir Holding B.V.	18,582,406	CHF 529.6m	0%	no data
5.19%	Premier Fund Managers Ltd.	1,712,407	CHF 48.8m	0%	0.61%
3.33%	Rudolf Maag	1,100,000	CHF 31.4m	0%	no data
3.01%	Newtyn Management, LLC	993,573	CHF 28.3m	0%	3.43%
1.68%	The Vanguard Group, Inc.	555,108	CHF 15.8m	2.65%	no data
1.46%	UBS Asset Management AG	482,772	CHF 13.8m	0.37%	no data
1%	Joh. Berenberg, Gossler & Co. KG, Asset Management Arm	330,624	CHF 9.4m	0%	0.36%
0.94%	HBM Partners Ltd.	309,000	CHF 8.8m	0%	0.98%
0.69%	Juan Gonzalez	227,842	CHF 6.5m	0%	no data
0.45%	Norges Bank Investment Management	149,724	CHF 4.3m	0%	no data
0.29%	ZKB Asset Management	94,660	CHF 2.7m	1.91%	0.01%
0.29%	Deka Investment GmbH	94,100	CHF 2.7m	0%	no data
0.24%	Dimensional Fund Advisors LP	78,389	CHF 2.2m	-3.25%	no data
0.22%	Zürcher Kantonalbank, Investment Arm	71,156	CHF 2.0m	-10.9%	0.02%
0.16%	A&G Fondos Sgiic S.A	53,544	CHF 1.5m	0%	0.78%
0.15%	Schroder Investment Management Limited	50,166	CHF 1.4m	0%	no data
0.14%	LBP AM	46,979	CHF 1.3m	0%	0.01%
0.14%	Pictet Asset Management SA	44,602	CHF 1.3m	0%	no data
0.13%	Driehaus Capital Management LLC	43,389	CHF 1.2m	0%	0.01%
0.11%	State Street Global Advisors, Inc.	35,775	CHF 1.0m	0.01%	no data
0.084%	Charles Schwab Investment Management, Inc.	27,581	CHF 786.1k	0%	no data
0.08%	Verwaltungs & Privat Bank AG, Asset Management Arm	26,300	CHF 749.6k	0%	0.36%
0.071%	Jane Salik	23,511	CHF 670.1k	0%	no data
0.07%	Valiant Bank AG, Asset Management Arm	22,965	CHF 654.5k	0%	0.07%
0.068%	Klaus Wilden	22,436	CHF 639.4k	0%	no data